White House Warns of Cannabis Health Risks and Youth Marketing Practices

The White House Office of National Drug Control Policy has issued a warning about the potential health dangers associated with marijuana use and criticized the cannabis industry's marketing tactics. According to officials, there is growing concern over evidence linking cannabis to health conditions such as psychosis. The administration also accused the industry of "adopting strategies similar to Big Tobacco’s historical targeting of young audiences," raising the stakes in ongoing debates about cannabis policy and regulation

The warning comes amid a flurry of legislative and regulatory activity at both state and federal levels. Bipartisan U.S. senators recently discussed the Trump administration's move to reschedule cannabis, with opinions ranging from cautious support to outright skepticism. Some lawmakers argue that the rescheduling effort does not go far enough, while others have softened their stance after hearing from constituents who use cannabis for medical purposes. Meanwhile, in Pennsylvania, Republican gubernatorial candidate Stacy Garrity stated she would veto any marijuana legalization bill, expressing doubt that such legislation would pass as long as Senate Republicans remain in control

State-level regulatory actions also continue to shape the cannabis landscape. The New York Office of Cannabis Management has opened applications for marijuana farmers’ markets and “Cannabis Showcase Events,” signaling new opportunities for small producers under recently adopted rules. In contrast, Israel’s health ministry is proposing to scale back medical cannabis access, particularly by phasing out smoking as a delivery method. These differing approaches highlight the complex patchwork of cannabis regulation worldwide

The debate extends beyond government as business and advocacy groups weigh in. The Wine & Spirits Wholesalers of America criticized the House of Representatives for omitting provisions in the Farm Bill that could have delayed or altered the upcoming ban on hemp THC products, calling it a "missed opportunity." Meanwhile, medical experts such as Peter Grinspoon of Massachusetts General Hospital and Harvard Medical School note a growing trend of seniors turning to cannabis for relief from age-related health issues. As Grinspoon wrote, “seniors are increasingly turning to cannabis to find relief from the medical indignities of aging.”

Local and federal agencies are also grappling with the complexities of cannabis and hemp product regulation. For example, Harris County, Texas, will no longer accept charges for THC vape pen possession due to difficulties in distinguishing the source of THC in these products. Additionally, the Department of Defense and the U.S. Embassy in Mexico have both issued warnings about the use and possession of cannabis-derived products, reflecting ongoing legal ambiguities and enforcement challenges

From the OG Lab newsroom perspective, the White House’s renewed focus on cannabis health risks and industry marketing could prompt stricter oversight and renewed public debate. As the regulatory landscape continues to shift, industry stakeholders should closely monitor federal positioning and evolving state-level rules. This development signals that health and youth protection will remain at the forefront of cannabis policy discussions in the U.S. and abroad